{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:15:46Z","timestamp":1784837746155,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101451","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:33:38Z","timestamp":1784244818000},"page":"101451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis"],"prefix":"10.1016","volume":"88","author":[{"given":"Hongchao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Tuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengde","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Fung","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Leong","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3262-7179","authenticated-orcid":false,"given":"Qinguo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-6916","authenticated-orcid":false,"given":"Liuya","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-329X","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101451_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063142","article-title":"Targeting the warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101451_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cac2.12607","article-title":"Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma","volume":"44","author":"Cai","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.drup.2026.101451_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12943-024-01988-y","article-title":"Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101451_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101451_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2020.11.002","article-title":"PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability","volume":"501","author":"Che","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101451_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","article-title":"NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism","volume":"23","author":"Chen","year":"2016","journal-title":"Cell. Metab."},{"key":"10.1016\/j.drup.2026.101451_bib7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101451_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2026.101451_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-025-07854-z","article-title":"SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation","volume":"16","author":"El Motiam","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101451_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101451_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126174","article-title":"Proteomic profiling of BRAFV600E mutant colon cancer cells reveals the involvement of nucleophosmin\/c-Myc AXIS IN MODULATING THE RESPONSE AND RESISTANCE to BRAF inhibition by vemurafenib","volume":"22","author":"Grb\u010di\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101451_bib12","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101451_bib13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","article-title":"Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma","volume":"43","author":"Huang","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drup.2026.101451_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010437","article-title":"New therapeutics for HCC: does tumor immune microenvironment matter?","volume":"24","author":"Khanam","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101451_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00432-018-2672-y","article-title":"Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines","volume":"144","author":"Kim","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101451_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2635","article-title":"Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism","volume":"8","author":"Krstic","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101451_bib17","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","article-title":"Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model","volume":"71","author":"Kumar","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101451_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2026.101451_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/1078-0432.CCR-20-3094","article-title":"Phase II study of avelumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101451_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101401","article-title":"Research advancements on sumoylation in gastrointestinal cancers","volume":"106","author":"Li","year":"2025","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.drup.2026.101451_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/0115748928275025231213103658","article-title":"Comprehensive bioinformatic analysis reveals an autophagy-related gene signature for predicting outcome, immune status, and drug sensitivity in hepatocellular carcinoma","volume":"20","author":"Liu","year":"2025","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101451_bib22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jgh.15775","article-title":"SUMOylation of methyltransferase-like 3 facilitates colorectal cancer progression by promoting circ_0000677 in an m(6) A-dependent manner","volume":"37","author":"Liu","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2026.101451_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143377","article-title":"Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma","volume":"131","author":"Loong","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2026.101451_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101451_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101015","article-title":"CRISPR\/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS\/SOD1-dependent mitochondrial oxidative stress","volume":"71","author":"Lu","year":"2023","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101451_bib26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-024-07214-3","article-title":"SPINK13 acts as a tumor suppressor in hepatocellular carcinoma by inhibiting Akt phosphorylation","volume":"15","author":"Lun","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101451_bib27","article-title":"SOX12 facilitates hepatocellular carcinoma progression and metastasis through promoting regulatory T-cells infiltration and immunosuppression","volume":"11","author":"Luo","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.drup.2026.101451_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101173","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101451_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","article-title":"ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis","volume":"23","author":"Mo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101451_bib30","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4251\/wjgo.v15.i8.1400","article-title":"Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370\/PIM1 axis-regulated glycolysis","volume":"15","author":"Pan","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.drup.2026.101451_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamaoncol.2020.3381","article-title":"The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review","volume":"7","author":"Pinter","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101451_bib32","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.7150\/thno.82132","article-title":"Protein phosphatase 2A-B55beta mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling","volume":"13","author":"Qian","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101451_bib33","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/s41467-021-25033-4","article-title":"TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation","volume":"12","author":"Qin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101451_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2020.09.001","article-title":"Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: a theoretical model","volume":"71","author":"Rada","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101451_bib35","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101451_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2025.03.033","article-title":"Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC","volume":"83","author":"Rimassa","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2026.101451_bib37","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1038\/s41467-024-53412-0","article-title":"Stepwise phosphorylation and SUMOylation of PIDD1 drive PIDDosome assembly in response to DNA repair failure","volume":"15","author":"Shah","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101451_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101181","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"Shi","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101451_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126501","article-title":"Orlistat resensitizes sorafenib-resistance in hepatocellular carcinoma cells through modulating metabolism","volume":"23","author":"Shueng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101451_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101208","article-title":"Rational design of peptides to overcome drug resistance by metabolic regulation","volume":"79","author":"Sun","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101451_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2026.101451_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12033-024-01055-3","article-title":"Lipopolysaccharide-educated cancer-associated fibroblasts facilitate malignant progression of ovarian cancer cells via the NF-kB\/IL-6\/JAK2 signal transduction","volume":"67","author":"Wang","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.drup.2026.101451_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.drup.2026.101451_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41418-024-01437-9","article-title":"SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy","volume":"32","author":"Wang","year":"2025","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.drup.2026.101451_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/0115748928265981231204044653","article-title":"Tyrosine kinase inhibitor lenvatinib causes cardiotoxicity by inducing endoplasmic reticulum stress and apoptosis through activating ATF6, IRE1alpha and PERK signaling pathways","volume":"20","author":"Wang","year":"2025","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101451_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102157","article-title":"Versatile recombinant SUMOylation system for the production of SUMO-modified protein","volume":"9","author":"Weber","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101451_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.30923","article-title":"CRAF methylation by PRMT6 regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2026.101451_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101176","article-title":"Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies","volume":"78","author":"Wu","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101451_bib49","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.7150\/ijbs.89568","article-title":"The role of TGF-\u03b2\/SMAD signaling in hepatocellular carcinoma: from mechanism to therapy and prognosis","volume":"20","author":"Xin","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.drup.2026.101451_bib50","article-title":"Epac1 activation by cAMP regulates cellular SUMOylation and promotes the formation of biomolecular condensates","volume":"8","author":"Yang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101451_bib51","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","article-title":"Targeting the peripheral neural-tumour microenvironment for cancer therapy","volume":"23","author":"Yaniv","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101451_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104765","article-title":"Insights into Sorafenib resistance in hepatocellular carcinoma: mechanisms and therapeutic aspects","volume":"212","author":"Yousef","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.drup.2026.101451_bib53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/JVI.80.1.342-352.2006","article-title":"Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection","volume":"80","author":"Yueh","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2026.101451_bib54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101451_bib55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101451_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41419-024-07271-8","article-title":"SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia","volume":"15","author":"Zhao","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101451_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101451_bib58","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41388-025-03335-x","article-title":"RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma","volume":"44","author":"Zhu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101451_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","article-title":"MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell. Death Dis."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:51:22Z","timestamp":1784836282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"alternative-id":["S1368764626001020"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101451","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101451"}}